Literature DB >> 28149666

A case of central nervous system nocardiosis in a patient with lupus treated with belimumab.

Richard Hc Lai1, Deborah Kim1, Florina Constantinescu2.   

Abstract

Belimumab was approved by the United States Food and Drug Administration in March 2011 as the first biological agent for treating active systemic lupus erythematosus (SLE). To the best of our knowledge, this is the first case report regarding a patient with SLE treated with belimumab who was diagnosed with central nervous system nocardiosis.

Entities:  

Keywords:  Belimumab; central nervous system; lupus; norcardiosis; systemic lupus erythematosus

Year:  2016        PMID： 28149666      PMCID： PMC5283570          DOI： 10.5152/eurjrheum.2016.15083

Source DB:  PubMed          Journal:  Eur J Rheumatol        ISSN： 2147-9720


  10 in total

Review 1.  Nocardiosis.

Authors:  P I Lerner
Journal:  Clin Infect Dis       Date:  1996-06       Impact factor: 9.079

Review 2.  Belimumab for systemic lupus erythematosus.

Authors:  Bevra Hannahs Hahn
Journal:  N Engl J Med       Date:  2013-04-18       Impact factor: 91.245

3.  Pulmonary nocardiosis in patients with connective tissue disease: A report of two cases.

Authors:  Shinya Hagiwara; Hiroto Tsuboi; Chihiro Hagiya; Masahiro Yokosawa; Tomoya Hirota; Hiroshi Ebe; Hiroyuki Takahashi; Hiroshi Ogishima; Hiromitsu Asashima; Yuya Kondo; Naoto Umeda; Takeshi Suzuki; Shigemi Hitomi; Isao Matsumoto; Takayuki Sumida
Journal:  Intractable Rare Dis Res       Date:  2014-02

Review 4.  Nocardial meningitis: case reports and review.

Authors:  J E Bross; G Gordon
Journal:  Rev Infect Dis       Date:  1991 Jan-Feb

Review 5.  Nocardiosis in systemic lupus erythematosus.

Authors:  C C Mok; K Y Yuen; C S Lau
Journal:  Semin Arthritis Rheum       Date:  1997-02       Impact factor: 5.532

6.  [Nocardia asteroides infection in a patient with systemic lupus erythematosus].

Authors:  P Mc-Nab; C Fuentealba; F Ballesteros; D Pacheco; M Alvarez; J Dabanch; E Cona
Journal:  Rev Med Chil       Date:  2000-05       Impact factor: 0.553

7.  Long-term safety profile of belimumab plus standard therapy in patients with systemic lupus erythematosus.

Authors:  Joan T Merrill; Ellen M Ginzler; Daniel J Wallace; James D McKay; Jeffrey R Lisse; Cynthia Aranow; Frank R Wellborne; Michael Burnette; John Condemi; Z John Zhong; Lilia Pineda; Jerry Klein; William W Freimuth
Journal:  Arthritis Rheum       Date:  2012-10

8.  Primary nocardial meningitis in systemic lupus erythematosus.

Authors:  C C Mok; C S Lau; S P Poon
Journal:  Br J Rheumatol       Date:  1995-02

Review 9.  [Nocardiosis--is it frequently observed after the introduction of new immunosuppressive agents in renal transplantation?].

Authors:  S Canet; V Garrigue; J Bismuth; G Chong; A Lesnik; P Taourel; G Mourad
Journal:  Nephrologie       Date:  2004

10.  Changing trends in infectious disease in heart transplantation.

Authors:  François Haddad; Tobias Deuse; Michael Pham; Prateeti Khazanie; Fernando Rosso; Helen Luikart; Hannah Valantine; Sebastian Leon; Thu A Vu; Sharon A Hunt; Philip Oyer; Jose G Montoya
Journal:  J Heart Lung Transplant       Date:  2009-10-22       Impact factor: 10.247
  10 in total
  1 in total

1.  Chronic relapsing neutrophilic meningitis as the sole manifestation of nocardiosis in a patient with mixed connective tissue disease.

Authors:  M Anthony Albornoz; Erin K Threlfall; Michael Philip Baldassari; Lawrence J Livornese
Journal:  IDCases       Date:  2022-03-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.